Harbin Medisan Pharmaceutical Co., Ltd. Stock: price and insider trades · China
哈三联
Harbin Medisan Pharmaceutical Co., Ltd.: what insiders have been doing
Harbin Medisan Pharmaceutical Co., Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). No insider at Harbin Medisan Pharmaceutical Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 7 July 2025.
Our records for Harbin Medisan Pharmaceutical Co., Ltd. go back to 2021, with no purchases and 4 sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 150,000 shares100.0% of flowA股XSHESZSE:173000009171321760
- 82,300 shares42.3% of flowA股XSHESZSE:173000005210172740
- 26,700 shares100.0% of flowA股XSHESZSE:173000009323280260
- 116,300 shares57.7% of flowA股XSHESZSE:173000004847435500
4 of 4 declarations
About Harbin Medisan Pharmaceutical Co., Ltd.
哈三联 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It specializes in the research and development of pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
